Back to Sculptor Capital LP Sculptor Capital LP

CRL

13 quarters

Position history for Sculptor Capital LPSculptor Capital LP's holdings in Charles River Laboratories International, Inc.

No. Sculptor Capital Management exited its CRL (Charles River Laboratories International) position in Q1 2022. Its Q4 2021 13F listed 18,582 shares worth $7M. Sculptor Capital Management already held CRL in its Q1 2019 13F, the earliest on record, and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$44.3M

Total Shares Change

-305,046

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q1
Latest
Exited
0
-100.0%
$00.0%$283.97
0
2021-Q4
Decreased
18,582
-53.9%
$7M0.1%$376.78
0
2021-Q3
Decreased
40,270
-36.8%
$16.6M0.1%$412.67
0
2021-Q2
Decreased
63,744
-20.0%
$23.6M0.2%$369.92
0
2021-Q1
Decreased
79,658
-55.5%
$23.1M0.2%$289.83
0
2020-Q4
Decreased
179,154
-48.5%
$44.8M0.2%$249.86
0
2020-Q3
Decreased
348,103
-15.7%
$78.8M0.5%$226.45
0
2020-Q2
Decreased
412,926
-10.3%
$72M0.6%$174.35
0
2020-Q1
Increased
460,468
+0.2%
$58.1M0.8%$126.21
41
2019-Q4
Increased
459,586
+5.2%
$70.2M0.7%$152.76
44
2019-Q3
Increased
437,086
+14.2%
$57.9M0.6%$132.37
47
2019-Q2
Increased
382,746
+25.5%
$54.3M0.3%$141.90
43
2019-Q1
First report
305,046
-
$44.3M0.3%$145.25
0

Other major holders of CRL: BlackRock Finance, Inc., Vanguard Group Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used